SLNG Stock Overview
SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company in Canada and the United States.
SLANG Worldwide Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.085|
|52 Week High||CA$1.29|
|52 Week Low||CA$0.05|
|1 Month Change||6.25%|
|3 Month Change||-43.33%|
|1 Year Change||-92.74%|
|3 Year Change||-98.81%|
|5 Year Change||n/a|
|Change since IPO||-99.29%|
Recent News & Updates
|SLNG||CA Pharmaceuticals||CA Market|
Return vs Industry: SLNG underperformed the Canadian Pharmaceuticals industry which returned -66.8% over the past year.
Return vs Market: SLNG underperformed the Canadian Market which returned -2% over the past year.
|SLNG Average Weekly Movement||26.1%|
|Pharmaceuticals Industry Average Movement||13.4%|
|Market Average Movement||10.8%|
|10% most volatile stocks in CA Market||19.4%|
|10% least volatile stocks in CA Market||4.3%|
Stable Share Price: SLNG is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 26% a week.
Volatility Over Time: SLNG's weekly volatility has increased from 21% to 26% over the past year.
About the Company
SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company in Canada and the United States. It owns, licenses, and/or markets 10 brands which serve flower, inhalable concentrate, and ingestible. SLANG Worldwide Inc. has a strategic partnership with Trulieve Cannabis Corp. to supply branded cannabis products in Massachusetts.
SLANG Worldwide Fundamentals Summary
|SLNG fundamental statistics|
Is SLNG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SLNG income statement (TTM)|
|Cost of Revenue||CA$22.01m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.49|
|Net Profit Margin||-130.59%|
How did SLNG perform over the long term?See historical performance and comparison
Is SLNG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SLNG?
Other financial metrics that can be useful for relative valuation.
|What is SLNG's n/a Ratio?|
Price to Sales Ratio vs Peers
How does SLNG's PS Ratio compare to its peers?
|SLNG PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
AQS Aequus Pharmaceuticals
MRV Nuvo Pharmaceuticals
THC THC Biomed Intl
SLNG SLANG Worldwide
Price-To-Sales vs Peers: SLNG is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.8x).
Price to Earnings Ratio vs Industry
How does SLNG's PE Ratio compare vs other companies in the CA Pharmaceuticals Industry?
Price-To-Sales vs Industry: SLNG is good value based on its Price-To-Sales Ratio (0.2x) compared to the Canadian Pharmaceuticals industry average (1.8x)
Price to Sales Ratio vs Fair Ratio
What is SLNG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||0.2x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate SLNG's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of SLNG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate SLNG's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate SLNG's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is SLANG Worldwide forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SLANG Worldwide has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine SLANG Worldwide's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- SLANG Worldwide competitive advantages and company strategy can generally be found in its financial reports archived here.
How has SLANG Worldwide performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SLNG is currently unprofitable.
Growing Profit Margin: SLNG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SLNG is unprofitable, and losses have increased over the past 5 years at a rate of 14.8% per year.
Accelerating Growth: Unable to compare SLNG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SLNG is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (72.5%).
Return on Equity
High ROE: SLNG has a negative Return on Equity (-139.96%), as it is currently unprofitable.
Discover strong past performing companies
How is SLANG Worldwide's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: SLNG's short term assets (CA$35.2M) exceed its short term liabilities (CA$13.2M).
Long Term Liabilities: SLNG's short term assets (CA$35.2M) exceed its long term liabilities (CA$24.4M).
Debt to Equity History and Analysis
Debt Level: SLNG has more cash than its total debt.
Reducing Debt: Insufficient data to determine if SLNG's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLNG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SLNG has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 18.6% each year.
Discover healthy companies
What is SLANG Worldwide current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SLNG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SLNG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SLNG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SLNG's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SLNG has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mark McManigle (66 yo)
Mr. Mark Drew McManigle serves as an Interim Chief Executive Officer and Chairman of the Board at SLANG Worldwide Inc since November 15, 2021. He has been Southwest Regional Head at SierraConstellation Par...
CEO Compensation Analysis
Compensation vs Market: Mark's total compensation ($USD44.20K) is below average for companies of similar size in the Canadian market ($USD186.28K).
Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.
Experienced Management: SLNG's management team is considered experienced (2 years average tenure).
Experienced Board: SLNG's board of directors are not considered experienced ( 0.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SLNG insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.4%.
SLANG Worldwide Inc.'s employee growth, exchange listings and data sources
- Name: SLANG Worldwide Inc.
- Ticker: SLNG
- Exchange: CNSX
- Founded: 2017
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: CA$8.363m
- Shares outstanding: 98.39m
- Website: https://slangww.com
- SLANG Worldwide Inc.
- 50 Carroll Street
- M4M 3G3
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/10 00:00|
|End of Day Share Price||2022/08/10 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.